CBE Stock Overview
Robertet SA produces and sells perfumes, aromas, and natural products.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for CBE from our risk checks.
Robertet SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €830.00 |
52 Week High | €830.00 |
52 Week Low | €710.00 |
Beta | 0.33 |
1 Month Change | 12.01% |
3 Month Change | 13.70% |
1 Year Change | 0.73% |
3 Year Change | -6.53% |
5 Year Change | 66.33% |
Change since IPO | 8,628.11% |
Recent News & Updates
Recent updates
Shareholder Returns
CBE | FR Chemicals | FR Market | |
---|---|---|---|
7D | 9.0% | -1.2% | -0.1% |
1Y | 0.7% | 10.6% | 3.1% |
Return vs Industry: CBE underperformed the French Chemicals industry which returned 9.8% over the past year.
Return vs Market: CBE underperformed the French Market which returned 2.9% over the past year.
Price Volatility
CBE volatility | |
---|---|
CBE Average Weekly Movement | 4.3% |
Chemicals Industry Average Movement | 5.5% |
Market Average Movement | 4.5% |
10% most volatile stocks in FR Market | 9.3% |
10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: CBE has not had significant price volatility in the past 3 months.
Volatility Over Time: CBE's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1850 | 2,153 | Jerome Bruhat | www.robertet.com |
Robertet SA produces and sells perfumes, aromas, and natural products. The company operates in four segments: Raw materials, Fragrances, Flavors, and Active Ingredients. It also produces organic essential oils and active ingredients.
Robertet SA Fundamentals Summary
CBE fundamental statistics | |
---|---|
Market cap | €1.81b |
Earnings (TTM) | €74.60m |
Revenue (TTM) | €721.15m |
24.4x
P/E Ratio2.5x
P/S RatioIs CBE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CBE income statement (TTM) | |
---|---|
Revenue | €721.15m |
Cost of Revenue | €329.34m |
Gross Profit | €391.80m |
Other Expenses | €317.21m |
Earnings | €74.60m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 23, 2024
Earnings per share (EPS) | 35.71 |
Gross Margin | 54.33% |
Net Profit Margin | 10.34% |
Debt/Equity Ratio | 66.4% |
How did CBE perform over the long term?
See historical performance and comparison